In addition to growth problems with the virus, Hall noted that one vaccine maker is still
making seasonal flu vaccine and has yet to switch over to production of the novel H1N1 product.
Not exact matches
With no head in place to hoard the immune response, the
vaccine might coax the body to
make enough stem - focused antibodies to protect against
flu, the researchers hoped, regardless of the
seasonal mutations occurring at the top.
It will enable manufacturers to rapidly create and
make available
vaccines for the
seasonal flu and pandemic outbreaks.
If there is such sustained transmission, versus imported cases from people who traveled to areas where the virus is circulating, several decisions would need to be
made, Hartl said, including whether to switch production from the
vaccine for
seasonal flu to the one for pandemic
flu, and whether to ramp up production of antivirals.
While this year's
vaccine is a much better match to the circulating
seasonal strains of influenza, the shifty nature of the virus and the need to pick the viruses used to
make global
vaccine stocks well before the onset of the
flu season can
make vaccine strain selection a shot in the dark.
During the 2014 - 15
flu season, the poor match between the virus used to
make the world's
vaccine stocks and the circulating
seasonal virus yielded a
vaccine that was less than 20 percent effective.
When
flu researchers learned about this new sugar - adorned H3N2 virus in 2014, they
made sure to include that strain in the 2016 — 17
seasonal flu vaccine so that immunized individuals would mount an immune response against it.
This raises concerns that
seasonal flu vaccine, which some companies are still
making, may be useless when the northern hemisphere's
flu season arrives later this year.